The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Does pathologic complete response predict for outcome in BRCA mutation carriers with triple-negative breast cancer?
Shani Paluch-Shimon
No relevant relationships to disclose
Eitan Friedman
No relevant relationships to disclose
Raanan Berger
No relevant relationships to disclose
Moshe Zvi Papa
No relevant relationships to disclose
Maya Dadiani
No relevant relationships to disclose
Neil Friedman
No relevant relationships to disclose
Moshe Shabtai
No relevant relationships to disclose
Douglas Zippel
No relevant relationships to disclose
Mordechai Gutman
No relevant relationships to disclose
Talia Golan
No relevant relationships to disclose
Raphael Catane
No relevant relationships to disclose
Ady Yosepovich
No relevant relationships to disclose
Tami Mekel Modiano
No relevant relationships to disclose
Bella Kaufman
No relevant relationships to disclose